Tag: GlobalData
India’s abdominal aortic stent grafts market to grow 7% CAGR through...
Rising incidence of abdominal aortic aneurysms and innovations like Terumo’s TREO stent-graft system to fuel market expansion in India
Eli Lilly’s Tirzepatide approved by NMPA in China, boosting market position
Tirzepatide’s debut as the first dual GIP and GLP-1 receptor agonist for obesity in China strengthens Eli Lilly’s presence
Biotech IPOs surge sixfold to $3.72 Billion in Q1 2024, highest...
Renewed investor optimism drives an increase in biotech IPO activity, with a record-setting first quarter following a two-year downturn
Viking Therapeutics’ obesity drug VK2735 could rival Eli Lilly’s Tirzepatide, says...
New Phase IIa results reveal significant weight loss, positioning VK2735 as a potential market leader amid increasing competition
Leqvio and Repatha drive revival of lipid-modifying agents market, reports GlobalData
Innovative therapies expected to lead the resurgence of the lipid-modifying agents market to $23 billion by 2030, after a decade-long decline
Oncology tests market in Japan to reach $30 million by 2033,...
High cancer incidence, driven by dietary habits and smoking, propels demand for advanced diagnostic technologies, with Japan leading the Asia-Pacific market in 2024
Private biotech rebounds with 46% growth in venture funding during Q1...
Private biotech venture financing saw a downturn during 2022 and 2023, influenced by macroeconomic challenges such as high interest rates and inflation
Biopharma industry’s response to EU reform proposals varies: GlobalData
Survey reveals mixed sentiments among industry leaders regarding impending EU regulatory changes
Anti-obesity drugs to dominate biopharma trends in 2024, reports GlobalData
Survey reveals obesity medications as key driver for industry growth in biopharmaceutical sector
US implements pre-emptive measures amid rising H5N1 cases
GlobalData reports enhanced pandemic preparedness and vaccine stockpiling to combat potential human transmission of H5N1 virus






























































